Výsledky vyhledávání - "Vera H M Deneer"

Akademický článek

Exploring the pharmacists’ role in optimising antithrombotic therapy in primary care: a qualitative study

Autor: Marcel L Bouvy, Vera H M Deneer, Jacqueline G van Paassen, Jaïr P Tan

Publikováno v: BMJ Open, Vol 14, Iss 3 (2024)

Objective In antithrombotic therapy, the balance between efficacy and safety is delicate, which makes it challenging for healthcare professionals, including pharmacists, to optimise therapy. Pharmacists may play an important role in optimising antith

Externí odkaz: https://doaj.org/article/c52f0875eb0849998b0c2e7eb92f59b1

Zobrazit plný text záznamu

Akademický článek

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines

Autor: Heshu Abdullah-Koolmees, Antonius M. van Keulen, Marga Nijenhuis, Vera H. M. Deneer

Publikováno v: Frontiers in Pharmacology, Vol 11 (2021)

Many studies have shown that the efficacy and risk of side effects of drug treatment is influenced by genetic variants. Evidence based guidelines are essential for implementing pharmacogenetic knowledge in daily clinical practice to optimize pharmaco

Externí odkaz: https://doaj.org/article/8bb649b16119415297be57b15561df90

Zobrazit plný text záznamu

Akademický článek

Use of Pharmacogenetic Drugs by the Dutch Population

Autor: Mohammad A. Alshabeeb, Vera H. M. Deneer, Amjad Khan, Folkert W. Asselbergs

Publikováno v: Frontiers in Genetics, Vol 10 (2019)

IntroductionThe Dutch Pharmacogenetics Working Group (DPWG) indicated a list of actionable genotypes that affect patients’ response to more 50 drugs; these drugs which show variable effects based on patients’ genetic traits were named as pharmaco

Externí odkaz: https://doaj.org/article/fc7ee493cd844a5d9c16fec8067c7819

Zobrazit plný text záznamu

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

Autor: Lianne Beunk, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne-Marie Buunk, Henk Jan Guchelaar, Elisa J. F. Houwink, Arne Risselada, Gerard A. P. J. M. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Roos van Westrhenen, Vera H. M. Deneer, Jan van der Weide

Publikováno v: European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics

The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate pharmacogenetics implementation in clinical practice by developing evidence-based guidelines to optimize pharmacotherapy. A guideline describing the gene-drug interaction between the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d87804d4af6dcbaf1b5d9f3f194979
https://cris.maastrichtuniversity.nl/en/publications/8434c9e0-c985-4bc8-a492-71fb47e9fdc5

Zobrazit plný text záznamu

Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate

Autor: Marga Nijenhuis, Bianca Soree, Wafa O. M. Jama, Nienke J. de Boer-Veger, Anne Marie Buunk, Henk-Jan Guchelaar, Elisa J. F. Houwink, Gerard A. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Arne Risselada

Publikováno v: European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics. Nature Publishing Group

Pharmacogenetics (PGx) studies the effect of heritable genetic variation on drug response. Clinical adoption of PGx has remained limited, despite progress in the field. To promote implementation, the Dutch Pharmacogenetics Working Group (DPWG) develo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f755520f566484b90f85d4cb382e207
http://hdl.handle.net/1887/3515272

Zobrazit plný text záznamu

Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan

Autor: Emma C. Hulshof, Maarten J. Deenen, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne-Marie Buunk, Elisa J. F. Houwink, Arne Risselada, Gerard A. P. J. M. Rongen, Ron H. N. van Schaik, Daan J. Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Henk-Jan Guchelaar, Jesse J. Swen

Publikováno v: European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics

The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate PGx implementation by developing evidence-based pharmacogenetics guidelines to optimize pharmacotherapy. This guideline describes the starting dose optimization of the anti-cancer dru

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ff773659822a1efb3a684e66e58279
https://hdl.handle.net/1887/3515271

Zobrazit plný text záznamu

Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate

Autor: Marga, Nijenhuis, Bianca, Soree, Wafa O M, Jama, Nienke J, de Boer-Veger, Anne Marie, Buunk, Henk-Jan, Guchelaar, Elisa J F, Houwink, Gerard A, Rongen, Ron H N, van Schaik, Jesse J, Swen, Daan, Touw, Jan, van der Weide, Roos, van Westrhenen, Vera H M, Deneer, Arne, Risselada

Publikováno v: European journal of human genetics : EJHG.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::37f61e3e151b32090f34abb8252ca479
https://pubmed.ncbi.nlm.nih.gov/36509836

Zobrazit plný text záznamu

Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and allopurinol, and MTHFR, folic acid and methotrexate

Autor: Karel H. van der Pol, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne Marie Buunk, Henk-Jan Guchelaar, Arne Risselada, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Elisa J. F. Houwink, Gerard A. Rongen

Publikováno v: European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cec37152e6fc9e7daaa1ea1275fd4f
https://hdl.handle.net/1887/3458834

Zobrazit plný text záznamu

Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

Autor: Maja Matic, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne-Marie Buunk, Elisa J. F. Houwink, Hans Mulder, Gerard A. P. J. M. Rongen, Jan van der Weide, Bob Wilffert, Jesse J. Swen, Henk-Jan Guchelaar, Vera H. M. Deneer, Ron H. N. van Schaik

Publikováno v: Eur J Hum Genet

The current Dutch Pharmacogenetics Working Group (DPWG) guideline, describes the gene-drug interaction between CYP2D6 and the opioids codeine, tramadol and oxycodone. CYP2D6 genotype is translated into normal metaboliser (NM), intermediate metabolise

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6930318714bbd8a3dac7c588c488077
https://europepmc.org/articles/PMC9553971/

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání